B: Improved glycemic control (lowers blood glucose levels aiding in T2DM patients, weight loss, reduction of cardiovascular risk factors, decreased major cardiovascular events. R: Thyroid C-cell tumors in rodent studies but in human studies such has been shown between GLP-1 agonists and thyroid cancer. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.